A prospective, single blinded, randomized, self-controlled study on the treatment of atrophic scars with cell-free fat extract combined hyaluronic acid

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039384

Enrollment

Unknown

Registered

2020-10-25

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic scar

Interventions

experimental group:Cell-free extract combined HA injection

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 50 years; 2. Male or female; 3. Patients with athophic scars; 4. The length of scars > 3cm, the depth > 2mm (under ultrasound); 5. Repeated other treatment interventions, with poor or ineffective results; 6. Patients or guardians who voluntarily sign informed consent after knowing all the treatment plans and risks are willing to accept self-control test and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or women with pregnancy planning; 2. Patients with wound or broken epidermis in the focus area; 3. Patients in other clinical trials; 4. Patients with serious basic diseases or mental and psychological disorders.

Design outcomes

Primary

Measure	Time frame
GAIS;	—

Countries

China

Contacts

Public ContactLiu wei

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

liuwei_md@126.com+86 13641957463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026